MedSkin Solutions Dr. Suwelack AG Receives FDA 510(k) Clearance for MatriDerm® - Its Three-Dimensional Acellular Collagen Elastin Dermal Matrix Portfolio
Comunicato Precedente
Comunicato Successivo
"We are pleased with receiving 510(k) clearance for our unique MatriDerm® products. This significant milestone represents our commitment at MedSkin Solutions Dr. Suwelack in bringing innovation and differentiated technologies to healthcare professionals and patients around the world," said Diana Ferro, President & CEO of MedSkin Solutions Dr. Suwelack AG.
"Like we have done across Europe, the Middle East, Asia, and Latin America our focus will be educating and supporting healthcare professionals and our partners as we look to commercialize MatriDerm® in the largest medical device market globally," said Jason Gugliuzza, Vice President Med Care Division.
About:
MedSkin Solutions Dr. Suwelack AG is a Germany-based expert in biotech solutions for tissue regeneration and skin health. Our technological core competence is our proprietary Advanced CryoSafe™ Method that allows us to maintain and refine the response of bioactive materials. Our science-based solutions create effective and easy-to-use treatments that deliver added value and serve equally patients and physicians. For our Customers, we develop the most effective, targeted and cost-efficient solutions in Regenerative Medicine, Advanced Wound Care and Professional Skin Care.
MedSkin Solutions Dr. Suwelack AG
Colonnaden 72
20354 Hamburg
Germany
P +49 40 356 204-711
W www.medskin-suwelack.com
Related Images
image1.jpg
Ufficio Stampa
PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom




